CVE-2014-8082

Public Exploit

Description

lib/functions/database.class.php in TestLink before 1.9.13 allows remote attackers to obtain sensitive information via unspecified vectors, which reveals the installation path in an error message.

Category

5.0
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 0.66%
Vendor Advisory testlink.org
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://seclists.org/fulldisclosure/2014/Oct/106 mailing list exploit patch
http://packetstormsecurity.com/files/128824/TestLink-1.9.12-Path-Disclosure.html patch exploit
http://karmainsecurity.com/KIS-2014-12 patch exploit
http://www.securityfocus.com/archive/1/533799/100/0/threaded mailing list
http://mantis.testlink.org/view.php?id=6651 vendor advisory
https://exchange.xforce.ibmcloud.com/vulnerabilities/97728 vdb entry
http://www.securityfocus.com/bid/70713 vdb entry
https://gitorious.org/testlink-ga/testlink-code/commit/c943e7a397f03e1f60b096c7e6eb94fdefd8a569

Frequently Asked Questions

What is the severity of CVE-2014-8082?
CVE-2014-8082 has been scored as a medium severity vulnerability.
How to fix CVE-2014-8082?
To fix CVE-2014-8082, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2014-8082 being actively exploited in the wild?
It is possible that CVE-2014-8082 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.